J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 2,140.65
+44.45 (2.12%)
At close: May 6, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 343.7 billion as of May 6, 2026. Its market cap has increased by 40.23% in one year.
Market Cap
343.70B
Enterprise Value
338.17B
Revenue
41.93B
Ranking
n/a
PE Ratio
45.10
Stock Price
2,140.65
Market Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 343.70B, an increase of 83,995.63%. That is a compound annual growth rate of 31.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 336.56B | 18.02% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.07T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 538.11B |
| GlaxoSmithKline Pharmaceuticals | 400.18B |
| AstraZeneca Pharma India | 205.84B |
| Granules India | 176.39B |
| Rubicon Research | 159.07B |
| Jubilant Pharmova | 148.66B |